Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1964 1
1966 1
1967 2
1972 1
1980 1
1981 1
2000 1
2001 2
2002 5
2003 4
2004 7
2005 10
2006 9
2007 13
2008 10
2009 12
2010 25
2011 23
2012 20
2013 26
2014 23
2015 25
2016 28
2017 21
2018 21
2019 38
2020 36
2021 45
2022 45
2023 38
2024 53

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

506 results

Results by year

Filters applied: . Clear all
Page 1
Drug-induced movement disorders.
Mehta SH, Morgan JC, Sethi KD. Mehta SH, et al. Neurol Clin. 2015 Feb;33(1):153-74. doi: 10.1016/j.ncl.2014.09.011. Neurol Clin. 2015. PMID: 25432728 Free article. Review.
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial.
Parkinson Study Group SURE-PD3 Investigators; Schwarzschild MA, Ascherio A, Casaceli C, Curhan GC, Fitzgerald R, Kamp C, Lungu C, Macklin EA, Marek K, Mozaffarian D, Oakes D, Rudolph A, Shoulson I, Videnovic A, Scott B, Gauger L, Aldred J, Bixby M, Ciccarello J, Gunzler SA, Henchcliffe C, Brodsky M, Keith K, Hauser RA, Goetz C, LeDoux MS, Hinson V, Kumar R, Espay AJ, Jimenez-Shahed J, Hunter C, Christine C, Daley A, Leehey M, de Marcaida JA, Friedman JH, Hung A, Bwala G, Litvan I, Simon DK, Simuni T, Poon C, Schiess MC, Chou K, Park A, Bhatti D, Peterson C, Criswell SR, Rosenthal L, Durphy J, Shill HA, Mehta SH, Ahmed A, Deik AF, Fang JY, Stover N, Zhang L, Dewey RB Jr, Gerald A, Boyd JT, Houston E, Suski V, Mosovsky S, Cloud L, Shah BB, Saint-Hilaire M, James R, Zauber SE, Reich S, Shprecher D, Pahwa R, Langhammer A, LaFaver K, LeWitt PA, Kaminski P, Goudreau J, Russell D, Houghton DJ, Laroche A, Thomas K, McGraw M, Mari Z, Serrano C, Blindauer K, Rabin M, Kurlan R, Morgan JC, Soileau M, Ainslie M, Bodis-Wollner I, Schneider RB, Waters C, Ratel AS, Beck CA, Bolger P, Callahan KF, Crotty GF, Klements D, Kostrzebski M, McMahon GM, Pothier L, Waikar SS, Lang A, Mestre T. Parkinson Study Group SURE-PD3 Investigators, et al. Among authors: mehta sh. JAMA. 2021 Sep 14;326(10):926-939. doi: 10.1001/jama.2021.10207. JAMA. 2021. PMID: 34519802 Free PMC article. Clinical Trial.
Integrated HIV testing, prevention, and treatment intervention for key populations in India: a cluster-randomised trial.
Solomon SS, Solomon S, McFall AM, Srikrishnan AK, Anand S, Verma V, Vasudevan CK, Balakrishnan P, Ogburn EL, Moulton LH, Kumar MS, Sachdeva KS, Laeyendecker O, Celentano DD, Lucas GM, Mehta SH; Indian National Collaboration on AIDS Study. Solomon SS, et al. Among authors: mehta sh. Lancet HIV. 2019 May;6(5):e283-e296. doi: 10.1016/S2352-3018(19)30034-7. Epub 2019 Apr 2. Lancet HIV. 2019. PMID: 30952565 Free PMC article. Clinical Trial.
Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology.
Mastenbroek SE, Vogel JW, Collij LE, Serrano GE, Tremblay C, Young AL, Arce RA, Shill HA, Driver-Dunckley ED, Mehta SH, Belden CM, Atri A, Choudhury P, Barkhof F, Adler CH, Ossenkoppele R, Beach TG, Hansson O. Mastenbroek SE, et al. Among authors: mehta sh. bioRxiv [Preprint]. 2023 Dec 7:2023.12.05.569878. doi: 10.1101/2023.12.05.569878. bioRxiv. 2023. Update in: Nat Commun. 2024 Jun 15;15(1):5133. doi: 10.1038/s41467-024-49402-x PMID: 38106128 Free PMC article. Updated. Preprint.
Paroxysmal dyskinesias.
Mehta SH, Morgan JC, Sethi KD. Mehta SH, et al. Curr Treat Options Neurol. 2009 May;11(3):170-8. doi: 10.1007/s11940-009-0020-x. Curr Treat Options Neurol. 2009. PMID: 19364451
Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology.
Mastenbroek SE, Vogel JW, Collij LE, Serrano GE, Tremblay C, Young AL, Arce RA, Shill HA, Driver-Dunckley ED, Mehta SH, Belden CM, Atri A, Choudhury P, Barkhof F, Adler CH, Ossenkoppele R, Beach TG, Hansson O. Mastenbroek SE, et al. Among authors: mehta sh. Nat Commun. 2024 Jun 15;15(1):5133. doi: 10.1038/s41467-024-49402-x. Nat Commun. 2024. PMID: 38879548 Free PMC article.
Optimal hepatitis C treatment adherence patterns and sustained virologic response among people who inject drugs: The HERO study.
Heo M, Norton BL, Pericot-Valverde I, Mehta SH, Tsui JI, Taylor LE, Lum PJ, Feinberg J, Kim AY, Arnsten JH, Sprecht-Walsh S, Page K, Murray-Krezan C, Anderson J, Litwin AH; HERO Study Group. Heo M, et al. Among authors: mehta sh. J Hepatol. 2024 May;80(5):702-713. doi: 10.1016/j.jhep.2023.12.020. Epub 2024 Jan 17. J Hepatol. 2024. PMID: 38242324
Conjugal Synucleinopathies: A Clinicopathologic Study.
Adler CH, Halverson M, Zhang N, Shill HA, Driver-Dunckley E, Mehta SH, Atri A, Caviness JN, Serrano GE, Shprecher DR, Belden CM, Sabbagh MN, Long K, Beach TG. Adler CH, et al. Among authors: mehta sh. Mov Disord. 2024 Jul;39(7):1212-1217. doi: 10.1002/mds.29783. Epub 2024 Apr 10. Mov Disord. 2024. PMID: 38597193
Biomarkers in Parkinson's disease.
Morgan JC, Mehta SH, Sethi KD. Morgan JC, et al. Among authors: mehta sh. Curr Neurol Neurosci Rep. 2010 Nov;10(6):423-30. doi: 10.1007/s11910-010-0144-0. Curr Neurol Neurosci Rep. 2010. PMID: 20809400 Review.
506 results